{"id":667614,"date":"2023-09-13T09:32:01","date_gmt":"2023-09-13T09:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=667614"},"modified":"2023-09-13T09:32:01","modified_gmt":"2023-09-13T09:32:01","slug":"sanfilippo-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-key-companies-abeona-therapeutics-phoenix-nest-alexion-allievex-corporation","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sanfilippo-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-key-companies-abeona-therapeutics-phoenix-nest-alexion-allievex-corporation_667614.html","title":{"rendered":"Sanfilippo Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Abeona Therapeutics, Phoenix Nest, Alexion Allievex Corporation"},"content":{"rendered":"
\n
\"Sanfilippo<\/a><\/div>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Sanfilippo Syndrome Type A (MPS IIIA) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sanfilippo Syndrome Type A (MPS IIIA), historical and forecasted epidemiology as well as the Sanfilippo Syndrome Type A (MPS IIIA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight’s “Sanfilippo Syndrome Type A (MPS IIIA) Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>” report delivers an in-depth understanding of the Sanfilippo Syndrome Type A (MPS IIIA), historical and forecasted epidemiology as well as the Sanfilippo Syndrome Type A (MPS IIIA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Sanfilippo Syndrome Overview<\/strong><\/p>\n

Sanfilippo (san-fuh-LEE-po) syndrome is a rare genetic metabolism disorder. A change in a single gene makes a child’s body unable to break down certain carbohydrates (sugars). This leads to serious problems in the brain and nervous system.<\/p>\n

The body makes long chains of sugar molecules called glycosaminoglycans (GAGs), also called mucopolysaccharides. They help build cartilage, connective tissue, nerve tissue, and skin, and help blood clots are used in the communication between cells. The body continually builds GAGs and, when their job is done, breaks them down through metabolism.<\/p>\n

\"\"<\/p>\n

Sanfilippo Syndrome Epidemiology Insight<\/strong><\/p>\n

A family history increases the risk for Sanfilippo syndrome, which affects about 1 in 70,000 births.<\/p>\n

Click here to learn more about the Sanfilippo Syndrome Market Landscape<\/a><\/strong><\/p>\n

The Report Covers the Sanfilippo Syndrome  Epidemiology Segmented by:<\/strong><\/p>\n